Verywell Health on MSN1y
What Are Myeloproliferative Disorders?
Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...
The American Journal of Managed Care5d
Personalizing MPN Disease Management and Monitoring
The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and ...
Cure Today4d
A Commitment to New Therapies for MPN Despite Scientific Challenges
One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment ...
Pharmaceutical Technology7d
Veliparib ER by AbbVie for Myeloproliferative Disorders: Likelihood of Approval
Veliparib ER is under clinical development by AbbVie and currently in Phase II for Myeloproliferative Disorders.
The American Journal of Managed Care6d
The Challenge of Managing Both Disease Symptoms and Drug Side Effects in Myelofibrosis
There’s a balance required to manage both the symptoms of myelofibrosis through treatment and the side effects caused by the ...
Pharmaceutical Technology6d
HMPL-306 by Hutchison MediPharma for Myeloproliferative Disorders: Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Myeloproliferative Disorders.
Medscape4y
Treatment Options for Essential Thrombocythemia and Polycythemia Vera
Polycythemia vera and essential thrombocythemia are the most common chronic myeloproliferative neoplasms ... are pushing therapeutic goals from disease control only to cure.
Cure Today5d
A Patient's Self-Advocacy Leads to an Essential Thrombocythemia Diagnosis in Her 30s
While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading ...